Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation (Q83169270)

From Wikidata

Jump to navigation Jump to search

scientific article published on 09 January 2009

Language	Label	Description	Also known as
English	Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation	scientific article published on 09 January 2009

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135232%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135232%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

phase I clinical trial

1 reference

based on heuristic

inferred from title

endometrial cancer

1 reference

based on heuristic

inferred from title

gynecologic oncology

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135232%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Perry W Grigsby

3

object named as

Perry W Grigsby

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135232%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Jeffrey M Fowler

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135232%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

William E Brady

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135232%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Robert S Mannel

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135232%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Janet S Rader

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135232%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

9 January 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135232%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135232%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

112

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135232%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135232%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

553-557

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135232%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Analysis of FIGO Stage IIIc endometrial cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

The role of radiotherapy for high-risk endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunities for cure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Utility and limitations of abdominal radiotherapy in the management of endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Systematic review of systemic therapy for advanced or recurrent endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Cisplatin, doxorubicin and cyclophosphamide (PAC) followed by radiation therapy in high-risk endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Incorporating toxicity considerations into the design of two-stage phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Stage III endometrial cancer: analysis of prognostic factors and failure patterns after adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

A phase I study of weekly cisplatin and whole abdominal radiation for the treatment of stage III and IV endometrial carcinoma: a Gynecologic Oncology Group pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) - Pilot trial of a phase I/II study: study protocol

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Assessment of prognostic factors in stage IIIA endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Uterine serous carcinoma: a comparison of therapy for advanced-stage disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Endometrial cancer: predictors of peritoneal failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Stage IIIC endometrioid corpus cancer includes distinct subgroups

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.026

7 January 2021

Identifiers

10.1016/J.YGYNO.2008.11.026

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135232%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19135232%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83169270&oldid=2043329716"